Literature DB >> 31388463

Usefulness of venous-to-arterial partial pressure of CO2 difference to assess oxygen supply to demand adequacy: effects of dobutamine.

Boulos Nassar1,2, Jihad Mallat1.   

Abstract

The central venous O2 saturation value and lactic acid levels are part of the diagnostic and therapeutic work up of patients in shock. These usual indicators of tissue hypoxia don't fully describe the adequacy of tissue perfusion. There is ample evidence that supplementing this data with the venous-to-arterial partial pressure of CO2 (PCO2) difference (ΔPCO2) complements the clinician's tools when treating patients with shock. Based on a modified Fick equation as it applies to CO2, in patients in a steady state, the ΔPCO2 reflects the cardiac output (CO). This observation has been shown to be of clinical value in resuscitating patients in shock. Moreover, the ΔPCO2 can be used to titrate inotropes, and differentiate the hemodynamic from the metabolic effect of dobutamine.

Entities:  

Keywords:  Pressure of CO2 (PCO2) gap; dobutamine; oxygen consumption; oxygen delivery (DO2); tissue hypoperfusion; venous oxygen saturation (SVO2)

Year:  2019        PMID: 31388463      PMCID: PMC6642911          DOI: 10.21037/jtd.2019.04.85

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  21 in total

1.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Venous hypercarbia associated with severe sepsis and systemic hypoperfusion.

Authors:  C E Mecher; E C Rackow; M E Astiz; M H Weil
Journal:  Crit Care Med       Date:  1990-06       Impact factor: 7.598

Review 3.  Use of central venous oxygen saturation to guide therapy.

Authors:  Keith R Walley
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

4.  Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock.

Authors:  J Bakker; M Coffernils; M Leon; P Gris; J L Vincent
Journal:  Chest       Date:  1991-04       Impact factor: 9.410

5.  Venoarterial CO(2) difference during regional ischemic or hypoxic hypoxia.

Authors:  B Vallet; J L Teboul; S Cain; S Curtis
Journal:  J Appl Physiol (1985)       Date:  2000-10

6.  Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock?

Authors:  Fabrice Vallée; Benoit Vallet; Olivier Mathe; Jacqueline Parraguette; Arnaud Mari; Stein Silva; Kamran Samii; Olivier Fourcade; Michèle Genestal
Journal:  Intensive Care Med       Date:  2008-07-08       Impact factor: 17.440

7.  Central venous-to-arterial carbon dioxide partial pressure difference in early resuscitation from septic shock: a prospective observational study.

Authors:  Jihad Mallat; Florent Pepy; Malcolm Lemyze; Gaëlle Gasan; Nicolas Vangrunderbeeck; Laurent Tronchon; Benoit Vallet; Didier Thevenin
Journal:  Eur J Anaesthesiol       Date:  2014-07       Impact factor: 4.330

8.  Time course of central venous-to-arterial carbon dioxide tension difference in septic shock patients receiving incremental doses of dobutamine.

Authors:  Jihad Mallat; Younes Benzidi; Julia Salleron; Malcolm Lemyze; Gaëlle Gasan; Nicolas Vangrunderbeeck; Florent Pepy; Laurent Tronchon; Benoit Vallet; Didier Thevenin
Journal:  Intensive Care Med       Date:  2013-12-05       Impact factor: 17.440

Review 9.  Clinical review: use of venous oxygen saturations as a goal - a yet unfinished puzzle.

Authors:  Paul van Beest; Götz Wietasch; Thomas Scheeren; Peter Spronk; Michaël Kuiper
Journal:  Crit Care       Date:  2011-10-24       Impact factor: 9.097

10.  Persistently high venous-to-arterial carbon dioxide differences during early resuscitation are associated with poor outcomes in septic shock.

Authors:  Gustavo A Ospina-Tascón; Diego F Bautista-Rincón; Mauricio Umaña; José D Tafur; Alejandro Gutiérrez; Alberto F García; William Bermúdez; Marcela Granados; César Arango-Dávila; Glenn Hernández
Journal:  Crit Care       Date:  2013-12-13       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.